… NRHirsh J Interactions of warfarin with drugs and food. … EHoffmann J Lack of interaction
between meloxicam and warfarin in … GLBesserer J Atorvastatin does not alter the anticoagulant …

… Contributors: David Lau and James Douketis were the principal coauthors of the executive
summary. All of the authors contributed substantially to the conception and design and to the …

This article discusses the perioperative management of antithrombotic therapy and is part of
the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th …

Background Patients who have a first episode of venous thromboembolism in the absence
of known risk factors for thrombosis (idiopathic thrombosis) are often treated with …

… The current iteration of this article differs from that of Douketis et al 6 in the Antithrombotic
and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical …

… JD Douketis—no relevant conflicts for present work. Consulting fees or honoraria from Janssen,
… Douketis contributed to the concept, analysis/interpretation of data, critical writing, and …

Background Many patients with the antiphospholipid antibody syndrome and recurrent
thrombosis receive doses of warfarin adjusted to achieve an international normalized ratio (INR) …

Background It is uncertain whether bridging anticoagulation is necessary for patients with
atrial fibrillation who need an interruption in warfarin treatment for an elective operation or …

BACKGROUND: Obesity is a common health problem that requires a long-term care
approach. We systematically reviewed long-term (≥ 2 y) studies investigating dietary/lifestyle, …

Context.—The most serious complication of deep vein thrombosis (DVT) or nonfatal pulmonary
embolism (PE) is fatal PE. However, reliable estimates as to the risk of fatal PE in patients …